|
Vaginal oestrogen versus placebo or no treatment
|
| Oestrogen 0,025–3 mg |
Placebo |
Simunic et al. 2003; Cardozo et al. 2001; Dessole et al. 2004; Sacco et al. 1990; Enzelsberger 1991–1; Enzelsberger 1991–2 |
| Triple therapy (local oestrogen (dose unclear), physiotherapy and electrostimulation) |
No treatment |
Holtedahl et al. 1998 |
| Premarin cream 2 gr/night (1.25 mg oestrogen) |
No treatment |
Henalla et al. 1989; Henalla et al. 1990 |
|
Different application methods of vaginal oestrogen
|
| Oestrogen Ring 0,5mg |
Oestrogen Pessary 0,5mg |
Lose et al. 2000 |
|
Vaginal oestrogen versus non-hormonal treatment
|
| Oestrogen cream 0,625mg + tolterodine |
Tolterodine |
Tseng et al. 2009; Serati et al. 2009 |
| Oestrogen ring 1mg (7,5microgram/24hr) |
Oral oxybutynin |
Nelken et al. 2011 |
| Oestrogen suppository 1mg |
Phenylpropanolamine |
Beisland et al. 1984 |
| Premarin cream 2 gr/night (1.25 mg oestrogen) |
Pelvic floor exercises |
Henalla et al. 1989; Henalla et al. 1990 |
| Premarin cream 2 gr/night (1.25 mg oestrogen) |
Electrostimulation |
Henalla et al. 1989 |
|
Different doses of vaginal oestrogen
|
| 1mg (application form unclear) |
3mg (application form unclear) |
Enzelsberger 1991 |
| 0,5-1mg (application form unclear) |
2mg (application form unclear) |
Enzelsberger 1990 |
|
Vaginal oestrogen versus oral oestrogen
|
| Oestrogen cream 0,625mg |
Oral oestrogen 0,625mg |
Long et al. 2006 |
|
Vaginal oestrogen vs combination therapy
|
| Oestrogen ovule 1mg + PFR |
Oestrogen Ovule 1mg |
Capobianco et al. 2012 |
| Triple therapy: Oestrogen and Lactobacilli Acidophili ovule plus pelvic floor rehabilitation (1mg oestrogen + 50 mg lyophilisate) |
Oestrogen ovule plus pelvic floor rehabilitation (1mg oestrogen) |
Capobianco et al. 2014 |
